Low-Level Exposure Cases in Lead Litigation Teleconference
October 29, 2008


Teleconference Audio Package
(includes audio and reference documents) – $149
Transcript – $49

To download the Product Order Form, click here. For questions, contact Allison Emery at 484-324-2755 x205 or allison.emery@litigationconferences.com.



Regulatory Background: The development of the 10 ug/dL threshold for prompting public health action/intervention
–1985: 25 ug/dL
–1991: 10ug/dL
–2007: suggestion that BLLs < 10ug/dL are harmful
Association of BLL Patterns with Developmental Outcomes
Health Care Perspective: Lead Prevention Programs in place
–Review of Child’s Environment
–Treatment Litigation: The use of BLL’s < 10 ug/dL (plaintiff’s perspective)
–The use of case studies / scientific studies
Defending against the use of BLL’s < 10 ug/dL (defendant’s perspective)
–Motions in Limine to prevent the introduction of case studies / scientific studies


Christian Gannon, Esq., Segal McCambridge Singer & Mahoney, Ltd., New York
Carl Baum, M.D., Associate Professor of Pediatrics, Yale University School of Medicine, Center For Children’s Environmental Toxicology, New Haven, CT
Paul Bottari, Esq., Wilson Elser Moskowitz Edelman & Dicker LLP, New York
John Daly, Esq., Of Counsel, Fitzgerald & Fitzgerald, P.C., New York
John Rosen, M.D., Clinical Professor, Department of Pediatrics and Director, Division of Environmental Sciences, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY
John Fitzgerald, Esq., Fitzgerald & Fitzgerald, P.C., Yonkers, NY